XML 11 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Combined and Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Balance (in shares) beginning at Dec. 31, 2022   49,323,531      
Balance beginning period at Dec. 31, 2022 $ 271,413 $ 5 $ 503,696 $ (1,752) $ (230,536)
Restricted common stock vesting, Shares   33,192      
Exercise of common stock options 18   18    
Exercise of common stock options, Shares   4,261      
Provision for pension benefit obligation 14     14  
Stock-based compensation expense 3,974   3,974    
Unrealized loss on available-for-sale securities 345     345  
Net Income (Loss) (32,038)       (32,038)
Balance end period at Mar. 31, 2023 243,726 $ 5 507,688 (1,393) (262,574)
Balance (in shares) period end at Mar. 31, 2023   49,360,984      
Balance (in shares) beginning at Dec. 31, 2023   50,140,233      
Balance beginning period at Dec. 31, 2023 179,250 $ 5 547,857 (2,724) (365,888)
Restricted common stock vesting, Shares   4,691      
Exercise of common stock options $ 246   246    
Exercise of common stock options, Shares 45,108 45,108      
Issuance of common stock, shares   10,272      
Issuance of common stock $ 87   87    
Provision for pension benefit obligation 35     35  
Stock-based compensation expense 4,873   4,873    
Unrealized loss on available-for-sale securities (4)     (4)  
Net Income (Loss) (31,968)       (31,968)
Balance end period at Mar. 31, 2024 $ 152,519 $ 5 $ 553,063 $ (2,693) $ (397,856)
Balance (in shares) period end at Mar. 31, 2024   50,200,304